Application of geranium polysaccharide in the preparation of liver-protecting medicine

A technology of geranium and polysaccharides, applied in the biological field, can solve problems such as obvious side effects and troubles

Active Publication Date: 2022-04-01
YUNNAN UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The current drugs for autoimmune hepatitis are some immunosuppressants such as glucocorticoids, and their side effects have always been one of the problems in clinical treatment.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of geranium polysaccharide in the preparation of liver-protecting medicine

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0022] The preparation method of the geranium polysaccharide is as follows: crush the geranium medicinal material, reflux and degrease it with methanol, extract it with 80°C water, and precipitate it with 80% ethanol. Deprecipitate to obtain refined geranium polysaccharide.

[0023] Geranium polysaccharide achieves hepatoprotective effect by reducing serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) values

[0024] The dose of geranium polysaccharide is 2-3 times a day, 0.4-1.8g each time.

[0025] The dose of geranium polysaccharide is 3 times a day, 1g each time.

[0026] The geranium polysaccharide is added with pharmaceutically acceptable auxiliary materials to prepare tablets, hard capsules, soft capsules, powders, pills and granules.

[0027] The geranium polysaccharide is used as an active ingredient or a medicinal carrier.

Embodiment 1

[0029] Preparation of crude polysaccharides from Geranium geranium: Grind the medicinal material of Geranium geranium, and degrease with methanol at 60° C. for 3 times. The degreased geranium medicinal material was boiled and extracted in hot water at 80° C. for 3 hours each time, and extracted twice in total. The extracts were combined and concentrated under reduced pressure. Precipitate the concentrated extract with 80% ethanol, centrifuge, and discard the supernatant to obtain the crude polysaccharide of geranium.

Embodiment 2

[0031] Refining of geranium polysaccharides: redissolve the obtained geranium polysaccharides with distilled water, remove protein by sevege method, centrifuge, discard the precipitate, a total of 5 times, until no more precipitate after centrifugation. Finally, the polysaccharide after removing the protein was concentrated under reduced pressure, freeze-dried, and the content of the polysaccharide was detected by the sulfuric acid-phenol method, and finally the refined geranium polysaccharide was obtained.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of biotechnology, and in particular relates to the preparation of geranium wilfordii Maxim. polysaccharide and its application in the development of liver-protecting drugs. The present invention adopts concanavalin A-induced immune liver injury model to investigate its hepatoprotective activity. Experimental results show that geranium polysaccharides can significantly reduce liver function indicators in mice with liver damage, and can be used to develop liver-protecting drugs, especially drugs for the treatment of immune liver damage. This invention is of great significance to the further development and utilization of geranium.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to a preparation method of geranium polysaccharide and its application in the development of liver-protecting drugs. Background technique [0002] Autoimmune hepatitis is a chronic hepatitis mediated by an autoimmune reaction. Its clinical features are varying degrees of serum transaminase AST, ALT elevation, hypergammaglobulinemia, positive autoantibodies, and histological features are infiltration of lymphocytes and plasma cells. Mainly interface hepatitis, severe cases can develop into cirrhosis. Currently, some immunosuppressants, such as glucocorticoids, are used to treat autoimmune hepatitis, and their side effects have always been one of the problems in clinical treatment. Combined with clinical practical problems, it is imminent to find hepatoprotective drugs with low toxicity and significant effect. [0003] Polysaccharides are widely found in plants, algae, fungi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/715A61K36/185A61P1/16
CPCA61K31/715A61K36/185A61P1/16A61K2236/331A61K2236/53
Inventor 刘录陈忠艺马晓霞周志宏张鹏祁燕倪广惠
Owner YUNNAN UNIV OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap